Effect of the angiotensin II receptor blocker olmesartan on the development of murine acute myocarditis caused by coxsackievirus B3

Clinical Science

Volumn 110, Issue 3, 2006, Pages 379-386

  Seko, Yoshinori ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Angiotensin II; Coxsackievirus B3; Infection; Inflammation; Lymphocyte; Myocarditis; Oxidative stress

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ANGIOTENSIN RECEPTOR ANTAGONIST; BIOLOGICAL MARKER; FAS LIGAND; GAMMA INTERFERON; HYDRALAZINE; INDUCIBLE NITRIC OXIDE SYNTHASE; OLMESARTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; COXSACKIE VIRUS B3; DNA DAMAGE; DRUG EFFECT; GENE EXPRESSION; HEART PROTECTION; INFLAMMATION; KILLER CELL; LYMPHOCYTE ACTIVATION; MALE; MOUSE; MYOCARDITIS; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SYSTOLIC BLOOD PRESSURE; VIRUS GENOME;

ACUTE DISEASE; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BLOOD PRESSURE; CYTOKINES; DEOXYGUANOSINE; DRUG EVALUATION, PRECLINICAL; ENTEROVIRUS B, HUMAN; ENTEROVIRUS INFECTIONS; GENOME, VIRAL; HEART RATE; HYDRALAZINE; IMIDAZOLES; INFLAMMATION MEDIATORS; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C3H; MYOCARDITIS; TETRAZOLES; VASODILATOR AGENTS;

EID: 33644779680     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20050299     Document Type: Article

References (31)

1. Hisada, Y., Sugaya, T., Yamanouchi, M. et al. (1999) Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice. J. Clin. Invest. 103, 627-635
2. Shao, J., Nangaku, M., Miyata, T. et al. (2003) Imbalance of T-cell subsets in angiotensin II-infused hypertensive rats with kidney injury. Hypertension 42, 31-38
3. Benediktsson, H., Chea, R., Davidoff, A. and Paul, C. L. (1996) Antihypertensive drug treatment in chronic renal allograft rejection in the rat. Transplantation 62, 1634-1642
4. Furukawa, Y., Matsumori, A., Hirozane, T. and Sasayama, S. (1996) Angiotensin II receptor antagonist TCV-116 reduces graft coronary artery disease and preserves graft status in a murine model. A comparative study with captopril. Circulation 93, 333-339
5. Tanaka, A., Matsumori, A., Wang, W. and Sasayama, S. (1994) An angiotensin II receptor antagonist reduces myocardial damage in an animal model of myocarditis. Circulation 90, 2051-2055
6. Yamamoto, K., Shioi, T., Uchiyama, K., Miyamoto, T., Sasayama, S. and Matsumori, A. (2003) Attenuation of virus-induced myocardial injury by inhibition of the angiotensin II type 1 receptor signal and decreased nuclear factor-κB activation in knockout mice. J. Am. Coll. Cardiol. 42, 2000-2006
7. Liu, H. W., Iwai, M., Takeda-Matsubara, Y. et al. (2002) Effect of estrogen and AT1 receptor blocker on neointima formation. Hypertension 40, 451-457
8. Suda, O., Tsutsui, M., Morishita, T. et al. (2004) Asymmetric dimethylarginine causes arteriosclerotic lesions in endothelial nitric oxide synthase-deficient mice. Involvement of renin-angiotensin system and oxidative stress. Arterioscler., Thromb., Vasc. Biol. 24, 1-7
9. Navalkar, S., Parthasarathy, S., Santanam, N. and Khan, B. V. (2001) Irbesartan, an angiotensin type 1 receptor inhibitor, regulates markers of inflammation in patients with premature atherosclerosis. J. Am. Coll. Cardiol. 37, 440-444
10. Koh, K. K., Ahn, J. Y., Han, S. H. et al. (2003) Pleiotropic effects of angiotensin II receptor blocker in hypertensive patients. J. Am. Coll. Cardiol. 42, 905-910
11. Fliser, D., Buchholz, K. and Haller, H. (2004) Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation. Circulation 110, 1103-1107
12. Parrillo, J. E., Aretz, H. T., Palacios, I., Fallon, J. T. and Block, P. C. (1984) The results of transvenous endomyocardial biopsy can frequently be used to diagnose myocardial diseases in patients with idiopathic heart failure: endomyocardial biopsies in 100 consecutive patients revealed a substantial incidence of myocarditis. Circulation 69, 93-101
13. Seko, Y., Shinkai, Y., Kawasaki, A. et al. (1991) Expression of perforin in infiltrating cells in murine hearts with acute myocarditis caused by coxsackievirus B3. Circulation 84, 788-795
14. Seko, Y., Yagita, H., Okumura, K. and Yazaki, Y. (1994) T-cell receptor Vβ gene expression in infiltrating cells in murine hearts with acute myocarditis caused by coxsackievirus B3. Circulation 89, 2170-2175
15. Seko, Y., Kayagaki, N., Seino, K., Yagita, H., Okumura, K. and Nagai, R. (2002) Role of Fas/FasL pathway in the activation of infiltrating cells in murine acute myocarditis caused by coxsackievirus B3. J. Am. Coll. Cardiol. 39, 1399-1403
16. Larsen, C. P., Alexander, D. Z., Hollenbaugh, D. et al. (1996) CD40-gp39 interactions play a critical role during allograft rejection. Transplantation 61, 4-9
17. + T cells, respectively, mediate Fas-dependent and perforin cytotoxic pathways. Eur. J. Immunol. 27, 415-420
18. Dix, R. D., Podack, E. R. and Cousins, S. W. (2003) Loss of the perforin cytotoxic pathway predisposes mice to experimental cytomegalovirus retinitis. J. Virol. 77, 3402-3408
19. Seko, Y., Takahashi, N., Yagita, H., Okumura, K. and Yazaki, Y. (1997) Expression of cytokine mRNAs in murine hearts with acute myocarditis caused by coxsackievirus B3. J. Pathol. 183, 105-108
20. Beck, M. A., Handy, J. and Levander, O. A. (2000) The role of oxidative stress in viral infections. Ann. N.Y. Acad. Sci. 917, 906-912
21. Suzuki, Y., Gomez-Guerrero, C., Shirato, I. et al. (2002) Susceptibility to T cell-mediated injury in immune complex disease is linked to local activation of renin-angiotensin system: The role of NF-AT pathway. J. Immunol. 169, 4136-4146
22. Rezkalla, S., Kloner, R. A., Khatib, G. and Khatib, R. (1990) Beneficial effects of captopril in acute coxsackievirus B3 murine myocarditis. Circulation 81, 1039-1046
23. Yung, R., Chang, S., Hemati, N., Johnson, K. and Richardson, B. (1997) Mechanisms of drug-induced lupus. IV. Comparison of procainamide and hydralazine with analogs in vitro and in vivo. Arthritis Rheum. 40, 1436-1443
24. Seko, Y., Matsuda, H., Kato, K. et al. (1993) Expression of intercellular adhesion molecule-1 in murine hearts with acute myocarditis caused by Coxsackievirus B3. J. Clin. Invest. 91, 1327-1336
25. Seko, Y., Takahashi, N., Azuma, M., Yagita, H., Okumura, K. and Yazaki, Y. (1998) Effects of in vivo administration of anti-B7-1/B7-2 monoclonal antibodies on murine acute myocarditis caused by coxsackievirus B3. Circ. Res. 82, 613-618
26. Seko, Y., Takahashi, N., Azuma, M., Yagita, H., Okumura, K. and Yazaki, Y. (1998) Expression of a costimulatory molecule CD40 in murine heart with acute myocarditis and reduction of inflammation by treatment with anti-CD40L/B7-1 monoclonal antibodies. Circ. Res. 83, 463-469
27. Seko, Y., Takahashi, N., Oshima, H. et al. (2001) Expression of tumor necrosis factor (TNF) ligand superfamily costimulatory molecules CD30L, CD27L, OX40L, and 4-1BBL in murine hearts with acute myocarditis caused by coxsackievirus B3. J. Pathol. 195, 593-603
28. Puvi, N., Weber, D. S., Rocic, P., Valppu, L., Taniyama, Y. and Griendling, K. K. (2002) Angiotensin II stimulation of NAD(P)H oxydase activity upstream mediators. Circ. Res. 91, 406-413
29. Tsuda, M., Iwai, M., Li, J. M. et al. (2005) Inhibitory effects of AT1 receptor blocker, olmesartan, and estrogen on atherosclerosis via anti-oxidative stress. Hypertension 45, 545-551
30. Schwarz, E. R., Montino, H., Fleischhauser, J., Klues, H. G., Dahl, J. and Hanrath, P. (1997) Angiotensin II receptor antagonist EXP3174 reduces infarct size comparable with enalaprilat and augments preconditioning in the pig heart. Cardiovasc. Drug Ther. 11, 687-695
31. Shimizu, M., Sjoquist, P. O., Wang, Q. D. and Ryden, L. (1999) Effects of the angiotensin AT1 receptor blocker candesartan on myocardial ischemic/reperfusion injury. J. Am. Soc. Nephrol. 10 (Suppl. 11), S137-S142